Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Net Sales	$ 1,929.3	$ 1,892.4	$ 4,939.2	$ 5,856.5
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 569.4	$ 535.7	$ 1,481.0	$ 1,670.4
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 149.7	$ 146.6	$ 445.0	$ 436.9
Research and development	85.9	114.4	272.0	328.2
Selling, general and administrative	790.0	826.4	2,283.9	2,461.6
Goodwill and intangible asset impairment			645.0	70.1
Restructuring and other cost reduction initiatives	16.2	5.4	89.2	17.0
Quality remediation	9.8	20.7	35.9	63.1
Acquisition, integration and related	9.1	(2.6)	15.7	8.5
Operating expenses	1,630.1	1,646.6	5,267.7	5,055.8
Operating Profit (Loss)	299.2	245.8	(328.5)	800.7
Other income (expense), net	10.6	(4.4)	17.4	(9.6)
Interest expense, net	(54.0)	(56.8)	(158.9)	(174.5)
Earnings (loss) before income taxes	255.8	184.6	(470.0)	616.6
Provision (benefit) for income taxes	9.7	(247.4)	1.2	(193.5)
Net Earnings (Loss)	246.1	432.0	(471.2)	810.1
Less: Net earnings (loss) attributable to noncontrolling interest	3.6	0.9	1.4	(0.8)
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc.	$ 242.5	$ 431.1	$ (472.6)	$ 810.9
Earnings (Loss) Per Common Share
Basic	$ 1.17	$ 2.10	$ (2.29)	$ 3.96
Diluted	$ 1.16	$ 2.08	$ (2.29)	$ 3.93
Weighted Average Common Shares Outstanding
Basic	207.1	205.3	206.8	204.8
Diluted	208.5	207.0	206.8	206.3